We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+6.48%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$76.3B
AUM Growth
+$3.71B
(+5.1%)
Cap. Flow
-$8.32B
Cap. Flow
% of AUM
-10.91%
Top 10 Holdings %
Top 10 Hldgs %
21.64%
Holding
2,644
New
223
Increased
746
Reduced
756
Closed
309
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Norfolk Southern
NSC
|
+$315M |
| 2 |
UnitedHealth
UNH
|
+$251M |
| 3 |
Union Pacific
UNP
|
+$248M |
| 4 |
Chevron
CVX
|
+$165M |
| 5 |
CYBR
CyberArk
CYBR
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$252M |
| 2 |
Aon
AON
|
+$184M |
| 3 |
Meta Platforms (Facebook)
META
|
+$160M |
| 4 |
PNC Financial Services
PNC
|
+$156M |
| 5 |
PayPal
PYPL
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.85% |
| 2 | Healthcare | 13.57% |
| 3 | Financials | 12.91% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Dine Brands
DIN
$452M
| $64K | ﹤0.01% |
959
+477
| +99% | +$35K |
|
1477
Genmab
GMAB
$19.2B
| $64K | ﹤0.01% |
1,742
| – | – |
|
1478
Hovnanian Enterprises
HOV
$807M
| $64K | ﹤0.01% |
+958
| New | +$58.5K |
|
1479
Hancock Whitney
HWC
$6.24B
| $64K | ﹤0.01% |
1,763
+658
| +60% | +$30.7K |
|
1480
Stagwell
STGW
$2.24B
| $64K | ﹤0.01% |
+8,757
| New | +$61.2K |
|
|
UMH
1481
UMH Properties
UMH
$1.36B
| $64K | ﹤0.01% |
4,374
+1,674
| +62% | +$27.5K |
|
|
PNT
1482
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $64K | ﹤0.01% |
+8,840
| New | +$65.6K |
|
|
CMA
1483
DELISTED
Comerica
CMA
| $63K | ﹤0.01% |
1,462
-2,709
| -65% | -$174K |
|
1484
Comtech Telecommunications
CMTL
$51.8M
| $63K | ﹤0.01% |
+5,080
| New | +$72.7K |
|
1485
Dillards
DDS
$9.56B
| $63K | ﹤0.01% |
207
-6,735
| -97% | -$2.39M |
|
1486
Hyster-Yale Materials Handling
HY
$665M
| $63K | ﹤0.01% |
+1,273
| New | +$46.7K |
|
1487
Myriad Genetics
MYGN
$312M
| $63K | ﹤0.01% |
2,750
+1,514
| +122% | +$30.7K |
|
1488
Pacira BioSciences
PCRX
$997M
| $63K | ﹤0.01% |
+1,544
| New | +$61.4K |
|
1489
PTC Therapeutics
PTCT
$6.12B
| $63K | ﹤0.01% |
1,320
-1,158
| -47% | -$52.9K |
|
1490
Sprout Social
SPT
$621M
| $63K | ﹤0.01% |
1,037
-7,250
| -87% | -$444K |
|
1491
Tiptree Inc
TIPT
$675M
| $63K | ﹤0.01% |
4,389
| – | – |
|
|
PTVE
1492
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $63K | ﹤0.01% |
7,977
+5,174
| +185% | +$53.2K |
|
1493
CryoPort
CYRX
$762M
| $62K | ﹤0.01% |
+2,584
| New | +$56.2K |
|
1494
Integra LifeSciences
IART
$1.34B
| $62K | ﹤0.01% |
1,092
+277
| +34% | +$15.6K |
|
1495
Lyell Immunopharma
LYEL
$360M
| $62K | ﹤0.01% |
1,327
+914
| +221% | +$48.9K |
|
1496
NovoCure
NVCR
$1.91B
| $62K | ﹤0.01% |
1,046
| – | – |
|
|
ODP
1497
DELISTED
ODP
ODP
| $62K | ﹤0.01% |
+1,399
| New | +$68.3K |
|
|
AQUA
1498
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $62K | ﹤0.01% |
+1,251
| New | +$58.4K |
|
1499
Ameresco
AMRC
$1.36B
| $61K | ﹤0.01% |
1,240
+610
| +97% | +$32.3K |
|
1500
Daktronics
DAKT
$1.04B
| $61K | ﹤0.01% |
+10,797
| New | +$44.1K |
|
Similar funds
QCM
Lazard Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, Lazard Asset Management held 2,644 positions worth $76.3B, up 5.1% from $72.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Lazard Asset Management withdrew a net $8.32B in Q1 2023, closing 309 positions and reducing 756 holdings. Its most notable exit was Linde, an estimated $56.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Fomento Económico Mexicano worth $11.2M.
- Lazard Asset Management's largest Q1 2023 buy was Fomento Económico Mexicano: 117,338 shares worth $11.2M.
- Lazard Asset Management added most to Norfolk Southern in Q1 2023, an estimated $315M increase.
- Lazard Asset Management's biggest Q1 2023 reduction was Analog Devices, cutting an estimated $252M.
- Lazard Asset Management fully exited Linde in Q1 2023, selling an estimated $56.6M.
- Lazard Asset Management's ten largest holdings make up 22% of its $76.3B portfolio in Q1 2023.
- Lazard Asset Management opened 223 new positions and closed 309 in Q1 2023.
- Lazard Asset Management's portfolio value rose 5.1% quarter-over-quarter to $76.3B.
Based on Lazard Asset Management's 13F filing for Q1 2023, filed 15 May 2023.